Carolina Vicente-Dueñas

Dr. Carolina Vicente-Dueñas

1. Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Michael GreenMichael Green
Michael Green
SKShingo Kihira
Shingo Kihira
CLChih Long Liu
Chih Long Liu
RNRamesh V. Nair
Ramesh V. Nair
RSRaheleh Salari
Raheleh Salari
AAAsh A Alizadeh
Ash A Alizadeh
Significance: Follicular lymphoma (FL) is a disease characterized by multiple relapses that are linked by a common progenitor bearing only a subset of the mutations found within the tumor that presents clinically. Inability to cure this disease may therefore be linked to the failure of current therapies to clear these early tumor-propagating clones. Here we further define the genetic hallmarks of this disease and model the steps in evolution through phylogenetic analysis of serial tumor biopsies. This identified CREBBP mutations as early events in genome evolution that are enriched within tumor cell progenitors and provided evidence that these mutations act by allowing immune evasion. This highlights CREBBP mutations as an attractive therapeutic target in FL and provides insight into their pathogenic mechanism.

23 December 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SMSara Mainardi
Sara Mainardi
NMNieves Mijimolle
Nieves Mijimolle
SFSarah Francoz
Sarah Francoz
CVCarolina Vicente-Dueñas
Carolina Vicente-Dueñas
ISIsidro Sanchez-Garcia
Isidro Sanchez-Garcia
MBMariano Barbacid
Mariano Barbacid
Significance: K-RAS oncogene-driven lung adenocarcinomas is one of the most malignant human tumors for which there are no efficacious therapeutic strategies. Here, we have used a mouse tumor model that closely recapitulates this human disease to illustrate that adult lung cells are uniquely sensitive to transformation by this oncogene. Monitoring lung cells at the single-cell level revealed that they respond differently to K-Ras oncogenic signals. Whereas K-Ras –expressing Clara cells required an inflammatory response to yield hyperplasias and adenomas, alveolar type II cells or their committed precursors led to the generation of malignant adenocarcinoma regardless of their surrounding microenvironment.

1 December 2007 in Annual Review of Genetics
Verified
Journal Article
Closed access
ĆCĆesar Cobaleda
Ćesar Cobaleda
MPMaría Pérez-Caro
María Pérez-Caro
CVCarolina Vicente-Dueñas
Carolina Vicente-Dueñas
ISIsidro Sanchez-Garcia
Isidro Sanchez-Garcia
Elucidation of the molecular mechanisms that underlie disease development is still a tremendous challenge for basic science, and a prerequisite to the development of new and disease-specific targeted therapies. This review focuses on the function of SNAI2, a member of the Snail family of zinc-finger transcription factors, and discusses its possible role in disease development. SNAI2 has been implicated in diseases of melanocyte development and cancer in humans. Many malignancies arise from a rare population of cells that alone have the ability to self-renew and sustain the tumor (i.e., cancer stem cells). SNAI2 controls key aspects of stem cell function in mouse and human, suggesting that similar mechanisms control normal development and cancer stem cell properties. These insights are expected to contribute significantly to the genetics of cancer and to the development of both cancer therapy and new methods for assessing treatment efficacy.

1 December 2015 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
AMAlberto Martín-Lorenzo
Alberto Martín-Lorenzo
JHJulia Hauer
Julia Hauer
CVCarolina Vicente-Dueñas
Carolina Vicente-Dueñas
FAFranziska Auer
Franziska Auer
IGInés González-Herrero
Inés González-Herrero
ABArndt Borkhardt
Arndt Borkhardt
Earlier in the past century, infections were regarded as the most likely cause of childhood B-cell precursor acute lymphoblastic leukemia (pB-ALL). However, there is a lack of relevant biologic evidence supporting this hypothesis. We present in vivo genetic evidence mechanistically connecting inherited susceptibility to pB-ALL and postnatal infections by showing that pB-ALL was initiated in Pax5 heterozygous mice only when they were exposed to common pathogens. Strikingly, these murine pB-ALLs closely resemble the human disease. Tumor exome sequencing revealed activating somatic, nonsynonymous mutations of Jak3 as a second hit. Transplantation experiments and deep sequencing suggest that inactivating mutations in Pax5 promote leukemogenesis by creating an aberrant progenitor compartment that is susceptible to malignant transformation through accumulation of secondary Jak3 mutations. Thus, treatment of Pax5+/− leukemic cells with specific JAK1/3 inhibitors resulted in increased apoptosis. These results uncover the causal role of infection in pB-ALL development. Significance: These results demonstrate that delayed infection exposure is a causal factor in pB-ALL. Therefore, these findings have critical implications for the understanding of the pathogenesis of leukemia and for the development of novel therapies for this disease. Cancer Discov; 5(12); 1328–43. ©2015 AACR. See related commentary by Greaves and Müschen, p. 1244. This article is highlighted in the In This Issue feature, p. 1225

1 June 2018 in Trends in Cancer
Verified
Journal Article
Closed access
CVCarolina Vicente-Dueñas
Carolina Vicente-Dueñas
JHJulia Hauer
Julia Hauer
ĆCĆesar Cobaleda
Ćesar Cobaleda
ABArndt Borkhardt
Arndt Borkhardt
ISIsidro Sanchez-Garcia
Isidro Sanchez-Garcia

27 November 2008 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MPMaría Pérez‐Caro
María Pérez‐Caro
ĆCĆesar Cobaleda
Ćesar Cobaleda
IGInés González‐Herrero
Inés González‐Herrero
CVCarolina Vicente-Dueñas
Carolina Vicente-Dueñas
CBCamino Bermejo‐Rodríguez
Camino Bermejo‐Rodríguez
ISIsidro Sanchez-Garcia
Isidro Sanchez-Garcia
In human cancers, all cancerous cells carry the oncogenic genetic lesions. However, to elucidate whether cancer is a stem cell‐driven tissue, we have developed a strategy to limit oncogene expression to the stem cell compartment in a transgenic mouse setting. Here, we focus on the effects of the BCR‐ABLp210 oncogene, associated with chronic myeloid leukaemia (CML) in humans. We show that CML phenotype and biology can be established in mice by restricting BCR‐ABLp210 expression to stem cell antigen 1 (Sca1)+ cells. The course of the disease in Sca1‐BCR‐ABLp210 mice was not modified on STI571 treatment. However, BCR‐ABLp210‐induced CML is reversible through the unique elimination of the cancer stem cells (CSCs). Overall, our data show that oncogene expression in Sca1+ cells is all that is required to fully reprogramme it, giving rise to a full‐blown, oncogene‐specified tumour with all its mature cellular diversity, and that elimination of the CSCs is enough to eradicate the whole tumour. There is a [Have you seen ...?][1] (February 2009) associated with this Article. [1]: http://dx.doi.org/10.1038/emboj.2008.292